Cantel Medical Corp. (NYSE:CMD)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $93.12 and last traded at $86.47, with a volume of 23997 shares trading hands. The stock had previously closed at $84.66.
Several equities research analysts recently weighed in on CMD shares. BidaskClub upgraded shares of Cantel Medical from a “buy” rating to a “strong-buy” rating in a research note on Friday, December 11th. Zacks Investment Research raised shares of Cantel Medical from a “hold” rating to a “strong-buy” rating and set a $88.00 price target for the company in a report on Monday, December 21st. CJS Securities began coverage on shares of Cantel Medical in a report on Friday, October 23rd. They set an “outperform” rating and a $70.00 target price for the company. Sidoti lowered shares of Cantel Medical from a “buy” rating to a “neutral” rating in a report on Tuesday. Finally, Needham & Company LLC lowered shares of Cantel Medical from a “buy” rating to a “hold” rating in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, one has given a buy rating and two have given a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $74.80.
The business’s 50-day moving average price is $78.90 and its two-hundred day moving average price is $60.65. The company has a market capitalization of $3.48 billion, a P/E ratio of 98.10, a PEG ratio of 1.67 and a beta of 1.54. The company has a debt-to-equity ratio of 1.28, a current ratio of 3.13 and a quick ratio of 2.31.
Institutional investors have recently added to or reduced their stakes in the company. Engineers Gate Manager LP bought a new position in shares of Cantel Medical during the third quarter valued at about $1,088,000. Aperio Group LLC increased its stake in shares of Cantel Medical by 9.3% in the third quarter. Aperio Group LLC now owns 8,964 shares of the company’s stock worth $394,000 after purchasing an additional 759 shares in the last quarter. Raymond James & Associates purchased a new position in shares of Cantel Medical in the third quarter worth about $231,000. Comerica Bank increased its stake in shares of Cantel Medical by 38.1% in the third quarter. Comerica Bank now owns 73,329 shares of the company’s stock worth $3,818,000 after purchasing an additional 20,221 shares in the last quarter. Finally, Dupont Capital Management Corp increased its stake in shares of Cantel Medical by 271.1% in the third quarter. Dupont Capital Management Corp now owns 15,723 shares of the company’s stock worth $691,000 after purchasing an additional 11,486 shares in the last quarter. Institutional investors own 95.01% of the company’s stock.
About Cantel Medical (NYSE:CMD)
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.
Featured Story: G-20
Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.